Vista Biologicals - Logo

(760) 438-0230

Request a quote

Revolutionizing the Biopharmaceutical Industry
Since 1981

Vista Biologicals provides highly specialized cell culture, process development and cGMP manufacturing services for the biotechnology and biopharmaceutical industries.

Learn more about us

Blood/Tissue Processing (Stem Cell Research)

Vista Biologicals Corporation provides a number of services for it’s clients working with Stem Cells as wells as the processing of blood and plasma.

We have isolated mononuclear cells (MNC’s) for cord blood as a source of Stem Cells used to treat patients with spinal cord injuries[1],[2]

We have processed and frozen umbilical cord tissue for long term storage. These tissues are being used as a source of epithelial and mesenchymal stem cells whose use as skin grafts to treat burn and diabetic patients as well as a number of other indication (such corneal resurfacing, Parkinson’s, heart disease and others) are being investigated.

Additionally we have processed both blood and plasma to prepare adsorbents used in the preparation of antisera to snake venom and other toxins.


 

[1] Phase I–II Clinical Trial Assessing Safety and Efficacy of  Umbilical Cord Blood Mononuclear Cell Transplant  Therapy of Chronic Complete Spinal Cord Injury, April 2016Cell Transplantation 25(11):1925-1943,

Hui Zhu, Waisang Poon, Yansheng Liu,  Gilberto Ka-Kit Leung, Yatwa Wong, Yaping Feng, Stephanie C. P. Ng, Kam Sze Tsang, David T. F. Sun, David K. Yeung, Caihong Shen, Fang Niu, Zhexi Xu, Pengju Tan, Shaofeng Tang, Hongkun Gao, Yun Cha, Kwok-Fai So, Robert Fleischaker, Dongming Sun, John Chen, Jan Lai, Wendy Cheng, and Wise Young

 

[2]Phase II US study is sited here https://clinicaltrials.gov/ct2/show/NCT03979742?term=Wise+Young&cond=Spinal+Cord+Injuries&cntry=US&draw=2&rank=1